Your browser doesn't support javascript.
loading
Gender Disparities in Cardiovascular Disease and Their Management: A Review.
Betai, Dhruva; Ahmed, Aamina S; Saxena, Prerna; Rashid, Hurria; Patel, Happy; Shahzadi, Atika; Mowo-Wale, Adetola G; Nazir, Zahra.
Afiliación
  • Betai D; General Practice, Pandit Deendayal Upadhyay Medical College, Rajkot, IND.
  • Ahmed AS; Internal Medicine, St. George's University School of Medicine, New York, USA.
  • Saxena P; Medicine and Surgery, K. S. Hegde Medical Academy, Mangalore, IND.
  • Rashid H; Basic Sciences, Fatima Jinnah Medical University, Lahore, PAK.
  • Patel H; Internal Medicine, Angeles University Foundation, Angeles City, PHL.
  • Shahzadi A; Medicine, Aziz Bhatti Shaheed Teaching Hospital, Gujrat, PAK.
  • Mowo-Wale AG; Internal Medicine, Obafemi Awolowo College of Health Sciences, Sagamu, NGA.
  • Nazir Z; Internal Medicine, Combined Military Hospital Quetta, Quetta, PAK.
Cureus ; 16(5): e59663, 2024 May.
Article en En | MEDLINE | ID: mdl-38836150
ABSTRACT
Worldwide, cardiovascular diseases (CVDs) are still the primary cause of death, and there are notable differences between sexes when it comes to symptoms/course and treatment. Due to evolving healthcare technologies, significant progress has been made in understanding CVDs. Hence, it is evident that gender disparities exist in the clinical presentation, prevalence, management, outcomes, and risk factors, including biological, behavioral, and sociocultural factors. This narrative review is designed to provide a generalized idea of gender disparities in CVDs. It aims to provide insights to prove the role of hormonal influences, genetic predispositions, and the difference in physiological outcomes owing to different genders. This review explores subtle distinctions in CVD across genders, including changes in structure, biology, and hormones that affect how illness presents and progresses. Lifestyle variables also influence sociocultural factors and gender disparities in risk profiles. Traditional risk factors, diabetes mellitus (DM), cholesterol levels, and smoking may have different weights and relevance in men and women. Moreover, age and other conventional risk variables have distinct effects on gender. Treatment efficacy may be impacted by the expression of gender-specific factors, emphasizing the necessity for customized strategies. Development of CVDs can be delayed or prevented, and its consequences can be lessened with the early identification and effective management of gender-specific factors. More investigation is necessary to clarify complex interactions between structural, biochemical, and hormonal aspects across genders in order to maximize treatment results and reduce the burden of CVDs.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos